Pcn388 - Patient Reported Outcomes in the Castration Resistant Prostate Cancer Registry (Pro-Capri) in the Netherlands

Value in Health- United Kingdom

doi 10.1016/j.jval.2018.09.2849

Full Text

Abstract

Available in

Date

Authors

Publisher

Elsevier BV

Related search

Patient Reported Outcomes in Metastatic Castration-Resistant Prostate Cancer

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Guideline Adherence in Docetaxel Treatment of Castration Resistant Prostate Cancer (CRPC) Patients in a Real-World Population: The Castration Resistant Prostate Cancer Registry (CAPRI) in the Netherlands

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Patient Reported Outcomes in Metastatic Castration-Resistant Prostate Cancer: A Systematic Review

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

The National Registry of Treatment Regimens in Patients With Metastatic Castration-Resistant Prostate Cancer in the Russian Federation

Onkourologiya
OncologyRadiologyUrologyNuclear MedicineNephrologyImagingSurgery
2019English

Visceral Disease in Castration-Resistant Prostate Cancer

European Urology
Urology
2014English

Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer

Yearbook of Paediatric Endocrinology
2019English

The Treatment Patterns of Castration Resistant Prostate Cancer in Japan

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Treatment Registry for Outcomes in Patients With Castration-Resistant Prostate Cancer (TRUMPET): A Methodology for Real-World Evidence and Research

Future Oncology
MedicineCancer ResearchOncology
2016English

Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer

Clinical Cancer Research
Cancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy